As previously reported, NF-κB inhibitor treatment significantly increases the chemosensitivity of the colon cancer cell line HT-29, and it effectively inhibits cell proliferation and induces apoptosis when used in combination with chemotherapeutic drugs [35]. Here, NFKB1 is linked to malignant colon neoplasm.